Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 10, 2025Current Drug Safety

Global Analysis of Regulatory Frameworks and Drug Safety Standards in the Drug Approval Process

View Full Paper
Ask AI
Bookmark
Share

Authors

GVGomase VSRSRupali SharmaSDSuchita P. Dhamane

Discussion

Loading...

Member takes

Overview

Analysis reveals drug approval processes of key regulatory authorities, highlighting harmonization efforts and challenges.

Key Points

  • The analysis shows the complexity of drug approval processes across various regulatory authorities.
  • Current regulatory frameworks vary significantly, indicating a need for global harmonization and clearer standards.
  • Regulatory authorities face challenges in balancing drug safety with the speed of approval in modern therapeutics.
  • Innovations in drug development are impacting regulatory pathways, necessitating ongoing adjustments and collaboration.

Cite This Study

VS et al. (2025) studied this question.

synapsesocial.com/papers/68c23d81b210217d6478d775https://doi.org/10.2174/0115748863392869250827042742
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Global Perspectives on Drug Regulatory Bodies: Roles, Challenges, and Collaborative Frameworks2025
  2. 2Intellectual Property Rights2025
  3. 3A Comparative Overview of Generic Drug Regulation in US, Europe, Australia and India2025
  4. 4Regulatory Approaches to Medical Devices: A Comparison between the United States, European Union, and India2025
  5. 5Regulatory Governance and the Evolution of Lean Regulators: Navigating the Complex Dynamics of Industry Relations in Pharmaceutical Oversight2025